On May 31st, 2024, Hualing Medicine submitted the latest monthly securities change report, which showed that the company's statutory/registered capital and issued shares remained unchanged in May, remaining at 2,000,000,000 shares and 1,055,588,761 shares, respectively. In addition, according to the company's share option plan, the number of exercisable share options at the end of this month is 52,897,591 shares, and no new shares have been issued this month. The company secretary, Yuan Yingxin, submitted the report to Hong Kong Securities Clearing Company on June 5, 2024 and confirmed that all relevant listing rules requirements have been complied with.

On May 31st, 2024, Hualing Medicine submitted the latest monthly securities change report, which showed that the company's statutory/registered capital and issued shares remained unchanged in May, remaining at 2,000,000,000 shares and 1,055,588,761 shares, respectively. In addition, according to the company's share option plan, the number of exercisable share options at the end of this month is 52,897,591 shares, and no new shares have been issued this month. The company secretary, Yuan Yingxin, submitted the report to Hong Kong Securities Clearing Company on June 5, 2024 and confirmed that all relevant listing rules requirements have been complied with.